UIH(SH:688271) Sou Hu Cai Jing·2026-01-08 11:27Core Viewpoint - The financial performance of United Imaging Healthcare (688271) shows significant growth in revenue and net profit for the first three quarters of 2025, indicating strong operational efficiency and market demand for its medical imaging and treatment solutions [2]. Financial Performance - For the first three quarters of 2025, the company's main revenue reached 8.859 billion yuan, a year-on-year increase of 27.39% [2]. - The net profit attributable to shareholders was 1.12 billion yuan, reflecting a year-on-year growth of 66.91% [2]. - The net profit excluding non-recurring items was 1.053 billion yuan, up 126.94% year-on-year [2]. - In Q3 2025 alone, the company reported a single-quarter revenue of 2.843 billion yuan, a 75.41% increase compared to the same quarter last year [2]. - The single-quarter net profit attributable to shareholders was 122 million yuan, showing a remarkable increase of 143.8% year-on-year [2]. - The single-quarter net profit excluding non-recurring items was 87.6141 million yuan, up 126.24% year-on-year [2]. - The company's debt ratio stands at 30.08%, with investment income of 606.847 million yuan and financial expenses of -438.233 million yuan [2]. - The gross profit margin is reported at 47.02% [2]. Market Activity - As of January 8, 2026, the stock price of United Imaging Healthcare closed at 134.02 yuan, with a slight decline of 0.13% [1]. - The turnover rate was 0.61%, with a trading volume of 50,200 hands and a total transaction amount of 675 million yuan [1]. - On January 8, the net inflow of main funds was 9.5598 million yuan, accounting for 1.42% of the total transaction amount, while retail investors saw a net inflow of 30.9545 million yuan, making up 4.58% of the total [1]. Analyst Ratings - In the last 90 days, 25 institutions have provided ratings for the stock, with 18 buy ratings and 7 hold ratings [2]. - The average target price set by institutions over the past 90 days is 17.312 billion yuan [2].